Dr Agarwal's Health [AGARWALEYE] vs Prevest Denpro [PREVEST] Detailed Stock Comparison

Dr Agarwal's Health Care Ltd

NSE
Loading...

Prevest Denpro Ltd.

BSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Dr Agarwal's Health Care Ltd wins in 5 metrics, Prevest Denpro Ltd. wins in 12 metrics, with 1 ties. Prevest Denpro Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Dr Agarwal's Health Care Ltd Prevest Denpro Ltd. Better
P/E Ratio (TTM) 109.80 27.33 Prevest Denpro Ltd.
Price-to-Book Ratio 7.17 4.69 Prevest Denpro Ltd.
Debt-to-Equity Ratio 48.68 0.00 Tie
PEG Ratio 77.92 6.44 Prevest Denpro Ltd.
EV/EBITDA 30.74 18.92 Prevest Denpro Ltd.
Profit Margin (TTM) 6.38% 27.78% Prevest Denpro Ltd.
Operating Margin (TTM) 14.22% 28.67% Prevest Denpro Ltd.
EBITDA Margin (TTM) 14.22% 28.67% Prevest Denpro Ltd.
Return on Equity 4.33% 17.20% Prevest Denpro Ltd.
Return on Assets (TTM) 2.27% 16.13% Prevest Denpro Ltd.
Free Cash Flow (TTM) $394.30M $128.49M Dr Agarwal's Health Care Ltd
Dividend Yield N/A 0.17% N/A
1-Year Return 17.19% -20.44% Dr Agarwal's Health Care Ltd
Price-to-Sales Ratio (TTM) 7.03 7.59 Dr Agarwal's Health Care Ltd
Enterprise Value $144.88B $4.68B Dr Agarwal's Health Care Ltd
EV/Revenue Ratio 7.33 6.57 Prevest Denpro Ltd.
Gross Profit Margin (TTM) 62.87% 79.68% Prevest Denpro Ltd.
Revenue per Share (TTM) $63 $59 Dr Agarwal's Health Care Ltd
Earnings per Share (Diluted) $3.99 $16.51 Prevest Denpro Ltd.
Beta (Stock Volatility) N/A 0.56 N/A

Dr Agarwal's Health Care Ltd vs Prevest Denpro Ltd. Stock Performance Analysis

Loading Price Chart...

AGARWALEYE
PREVEST

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Dr Agarwal's Health Care Ltd-0.10%-2.72%-2.40%3.65%-11.79%-12.18%
Prevest Denpro Ltd.-0.42%-0.84%-5.49%-5.28%-20.44%-18.59%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Dr Agarwal's Health Care Ltd17.19%9.38%9.38%9.38%9.38%9.38%
Prevest Denpro Ltd.-20.44%-9.34%356.55%356.55%356.55%356.55%

Performance & Financial Health Analysis: Dr Agarwal's Health Care Ltd vs Prevest Denpro Ltd.

MetricAGARWALEYEPREVEST
Market Information
Market Cap i₹138.86B₹5.42B
Market Cap CategoryMid capSmall cap
10 Day Avg. Volume i98,86215,100
90 Day Avg. Volume i169,21032,133
Last Close₹439.30₹381.90
52 Week Range₹371.50 - ₹568.00₹318.15 - ₹622.05
% from 52W High-22.66%-38.61%
All-Time High₹568.00 (Oct 16, 2025)₹686.00 (Jan 13, 2025)
% from All-Time High-22.66%-44.33%
Growth Metrics
Quarterly Revenue Growth0.23%0.24%
Quarterly Earnings Growth0.51%0.04%
Financial Health
Profit Margin (TTM) i0.06%0.28%
Operating Margin (TTM) i0.14%0.29%
Return on Equity (TTM) i0.04%0.17%
Debt to Equity (MRQ) i48.680.00
Cash & Liquidity
Book Value per Share (MRQ)₹61.13₹96.29
Cash per Share (MRQ)₹12.58₹61.36
Operating Cash Flow (TTM) i₹1.43B₹185.37M
Levered Free Cash Flow (TTM) i₹834.60M₹181.55M
Dividends
Last 12-Month Dividend Yield iN/A0.17%
Last 12-Month Dividend iN/A₹1.00

Valuation & Enterprise Metrics Analysis: Dr Agarwal's Health Care Ltd vs Prevest Denpro Ltd.

MetricAGARWALEYE (Apr 26, 2026)PREVEST (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i109.8027.33
Forward P/E i77.92N/A
PEG Ratio i77.926.44
Price to Sales (TTM) i7.037.59
Price to Book (MRQ) i7.174.69
Market Capitalization
Market Capitalization i₹138.86B₹5.42B
Enterprise Value i₹144.88B₹4.68B
Enterprise Value Metrics
Enterprise to Revenue i7.336.57
Enterprise to EBITDA i30.7418.92
Risk & Other Metrics
Beta iN/A0.56
Book Value per Share (MRQ) i₹61.13₹96.29

Financial Statements Comparison: Dr Agarwal's Health Care Ltd vs Prevest Denpro Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricAGARWALEYE (2025)PREVEST (2025)
Revenue/Sales i17.05B620.76M
Cost of Goods Sold i9.36B122.51M
COGS % of Revenue i54.9%19.7%
Gross Profit i7.69B498.25M
Gross Margin i45.1%80.3%
Research & Development iN/AN/A
Operating Income (EBIT) i2.49B205.13M
Operating Margin i14.6%33.0%
EBITDA i4.91B262.26M
EBITDA Margin i28.8%42.2%
Pre-Tax Income i1.60B242.50M
Pre-Tax Income % of Revenue i9.4%39.1%
Income Tax i495.10M60.95M
Income Tax % of Revenue i2.9%9.8%
Net Income (Profit) i1.10B181.55M
Profit Margin i6.5%29.2%

Balance Sheet & Liquidity Metrics

MetricAGARWALEYE (2025)PREVEST (2025)
Cash & Equivalents i1.04B608.98M
Total Current Assets i7.94B857.15M
Total Current Assets % of Revenue i46.6%138.1%
Total Current Liabilities i4.78B59.62M
Total Current Liabilities % of Revenue i28.0%9.6%
Long-Term Debt i8.08B0
Long-Term Debt % of Revenue i47.4%0.0%
Total Shareholders Equity i19.27B1.06B
Retained Earnings i-1.85B733.61M
Retained Earnings % of Revenue i-10.9%118.2%
Property, Plant & Equipment i6.60B13.99M

Cash Flow Statement Comparison

MetricAGARWALEYE (2025)PREVEST (2025)
Operating Cash Flow i1.43B185.37M
Operating Cash Flow % of Revenue i8.4%29.9%
Capital Expenditures i5.30M-19.68M
Free Cash Flow i394.30M128.49M
FCF Margin i2.3%20.7%
Debt Repayment i-2.03BN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricAGARWALEYEPREVEST
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i316.96M12.00M
Float Shares i60.08M2.17M
% Held by Insiders i75.49%79.09%
% Held by Institutions i16.46%0.00%
% Held by Public i8.05%20.91%

Dividend Analysis & Yield Comparison: Dr Agarwal's Health Care Ltd vs Prevest Denpro Ltd.

MetricAGARWALEYEPREVEST
Last 12-Month Dividend iN/A₹1.00
Last 12-Month Dividend Yield iN/A0.17%
3-Year Avg Annual Dividend iN/A₹0.33
3-Year Avg Dividend Yield iN/A0.17%
3-Year Total Dividends iN/A₹1.00
Ex-Dividend DateN/ASep 03, 2025